File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Ten-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients?

TitleTen-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients?
Authors
Issue Date2017
PublisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/
Citation
22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9 How to Cite?
AbstractObjective: To examine the outcomes ofre-transurethral resection (re-TUR) inpatients with non-muscle invasive bladdercancer (NMIBC). Patients and Methods: We retrospectivelyreviewed data from Jan 2004 to Dec 2014in Queen Mary and Tung Wah Hospitals.One-hundred-and-eight patients under-went re-TUR for NMIBC. Exclusion crite-ria included histology other thantransitional cell carcinoma (TCC), historyof upper tract TCC and macroscopicincomplete initial resection.Results: Fifty-five patients (51%) had T1tumor and 93 patients (86.1%) had high-grade (HG) disease on the initial resection.Muscularis propria was included in 38patients (35.2%) on the initial resection.After re-TUR, 8 patients (7.4%) hadupstaged to muscle-invasive disease while6 patients (5.6%) still had T1HG tumor inthe resection specimen. This resulted in achange of management to radical treat-ment in ten percent of patients. Allpatients with upstaged muscle-invasivedisease after re-TUR had HG tumor,87.5% had tumor larger than 3 cm and75% had T1 tumor on the initial resection.All 15 patients with low grade disease onthe initial resection did not show anyupstaging after re-TUR.Conclusion: Re-TUR remains an impor-tant treatment strategy to detect upstagingin bladder cancer especially in thosepatients with T1HG disease and withtumor larger than 3 cm.
DescriptionAbstract
Persistent Identifierhttp://hdl.handle.net/10722/241668
ISSN
2017 Impact Factor: 4.688
2015 SCImago Journal Rankings: 2.009

 

DC FieldValueLanguage
dc.contributor.authorWong, JKW-
dc.contributor.authorLai, TCT-
dc.contributor.authorTsnag, CF-
dc.contributor.authorHo, SHB-
dc.contributor.authorNg, ATL-
dc.contributor.authorMa, WK-
dc.contributor.authorTsu, HLJ-
dc.contributor.authorYiu, MK-
dc.date.accessioned2017-06-20T01:46:55Z-
dc.date.available2017-06-20T01:46:55Z-
dc.date.issued2017-
dc.identifier.citation22nd Annual Scientific Meeting of the Hong Kong Urological Association, Hong Kong, 20 November 2016. In BJU International, 2017, v. 119 n. suppl. 3, p. 9-
dc.identifier.issn1464-4096-
dc.identifier.urihttp://hdl.handle.net/10722/241668-
dc.descriptionAbstract-
dc.description.abstractObjective: To examine the outcomes ofre-transurethral resection (re-TUR) inpatients with non-muscle invasive bladdercancer (NMIBC). Patients and Methods: We retrospectivelyreviewed data from Jan 2004 to Dec 2014in Queen Mary and Tung Wah Hospitals.One-hundred-and-eight patients under-went re-TUR for NMIBC. Exclusion crite-ria included histology other thantransitional cell carcinoma (TCC), historyof upper tract TCC and macroscopicincomplete initial resection.Results: Fifty-five patients (51%) had T1tumor and 93 patients (86.1%) had high-grade (HG) disease on the initial resection.Muscularis propria was included in 38patients (35.2%) on the initial resection.After re-TUR, 8 patients (7.4%) hadupstaged to muscle-invasive disease while6 patients (5.6%) still had T1HG tumor inthe resection specimen. This resulted in achange of management to radical treat-ment in ten percent of patients. Allpatients with upstaged muscle-invasivedisease after re-TUR had HG tumor,87.5% had tumor larger than 3 cm and75% had T1 tumor on the initial resection.All 15 patients with low grade disease onthe initial resection did not show anyupstaging after re-TUR.Conclusion: Re-TUR remains an impor-tant treatment strategy to detect upstagingin bladder cancer especially in thosepatients with T1HG disease and withtumor larger than 3 cm.-
dc.languageeng-
dc.publisherWiley-Blackwell Publishing Ltd. The Journal's web site is located at http://www.bjui.org/-
dc.relation.ispartofBJU International-
dc.rightsPreprint This is the pre-peer reviewed version of the following article: [FULL CITE], which has been published in final form at [Link to final article]. Authors are not required to remove preprints posted prior to acceptance of the submitted version. Postprint This is the accepted version of the following article: [full citation], which has been published in final form at [Link to final article].-
dc.titleTen-year experience on retransurethral resection of non-muscle-invasive bladder cancer. Are we doing on the right patients?-
dc.typeConference_Paper-
dc.identifier.emailHo, SHB: hobrian@hku.hk-
dc.identifier.emailMa, WK: mwk054@hku.hk-
dc.identifier.emailTsu, HLJ: jamestsu@hku.hk-
dc.identifier.emailYiu, MK: pmkyiu@hku.hk-
dc.identifier.doi10.1111/bju.13768-
dc.identifier.hkuros272638-
dc.identifier.volume119-
dc.identifier.issuesuppl. 3-
dc.identifier.spage9-
dc.identifier.epage9-
dc.publisher.placeUnited Kingdom-
dc.customcontrol.immutablecsl 170718-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats